Amorphous pharmaceutical solids: preparation, characterization and stabilization.
By Lianyu Yu. Advanced Drug Delivery Reviews, 2001
1,280 citations recorded by the source corpus.
Subfields: Food Science, Materials Chemistry, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/96847ca79fd6391ce934793007391d10ff239a63
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Food Science
In Materials Chemistry
- Christopher J. H. Porter
- W. Charman
- S. Charman
- H. Williams
- R. Shanker
- Natalie L. Trevaskis
- Colin W. Pouton
- Sandeep Kalepu
In Pharmaceutical Science
- Christopher J. H. Porter
- W. Charman
- Natalie L. Trevaskis
- S. Charman
- H. Williams
- R. Shanker
- Colin W. Pouton
- Sandeep Kalepu
Citations in the corpus
- Insoluble drug delivery strategies: review of recent advances and business prospects (2015, positive): “But, excess of enthalpy, entropy and free energies of amorphous forms makes them prone to crystallization, leading to the formation of stable crystals 43 .”
- Strategies to Address Low Drug Solubility in Discovery and Development (2013, background): “This transformation can occur very rapidly on dissolution, complicating solubility measurements for the high energy form, and can also occur during storage in the solid state, particularly on exposure to moisture or heat (Yu, 2001; Pudipeddi and Serajuddin, 2005; Janssens and Van den Mooter, 2009).”